HK$45.72+40.07% · 3M
Moving avg
1W-0.31%
1M+15.63%
3M+35.75%
6M+14.30%
YTD+40.50%
1Y+48.35%
3Y+7.45%
5Y-62.21%
52-week range
$3.63100% of range$5.61
Company health
Value0/6
Growth6/6
Profitability6/6
Health6/6
Dividend0/6
Bull vs bear
Strengths
- Strong 23% net margin
- High return on equity (1064%)
- Revenue compounding 46% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$24.14B
Enterprise value
$17.51B
P/E ratio (TTM)
29.10x
P/S ratio (TTM)
6.59x
EV/EBITDA
17.34x
Per share & returns
EPS (TTM)
$0.15
Dividend yield
0.00%
Beta (1Y)
0.58
30-day change
+15.63%
Trading
Volume (24h)
29.41M
Previous close
HK$45.70
Shares outstanding
4.14B
About WuXi Biologics (Cayman) Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
HKEX
Symbol
2269.HK
WuXi Biologics (Cayman) Inc. is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on HKEX (China) and trade under the ticker 2269.HK.
Frequently asked questions
What is WuXi Biologics (Cayman) Inc.'s market cap?
WuXi Biologics (Cayman) Inc. (2269.HK) has a market capitalization of $24.14B.
What is WuXi Biologics (Cayman) Inc.'s P/E ratio?
WuXi Biologics (Cayman) Inc. trades at a price-to-earnings (P/E) ratio of 29.10.
What exchange does 2269.HK trade on?
2269.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,221.17+0.07%
$1.15T cap
Johnson & JohnsonJNJ
$261.41+0.21%
$629.97B cap
AbbVie Inc.ABBV
$250.64+0.75%
$442.82B cap
UnitedHealth Group IncorporatedUNH
$403.30-0.56%
$366.25B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.71+1.34%
$332.70B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap